Central Pontine Myelinolysis After Living-Donor Liver Transplant: A Report of 2 Cases.

Abstract

Here, we present 2 patients who developed central pontine myelinolysis after living-donor liver transplant. Both patients had abnormal sodium level before living-donor liver transplant. Patient 1 presented with severe hyponatremia on admission. After administration of 3% saline, her sodium level during the first 24 hours was kept at 100 mEq/L and then increased to 116 mEq/L during the next 24 hours. The level increased 5.8 mEq/L during the 4- to 5-hour transplant procedure. Patient 2 was admitted to the hospital with an unprovoked seizure. The serum sodium concentration was 111 mEq/L, which was treated with 3% saline infusion. Serum sodium concentration escalated to 118 mEq/L over an 8-hour period. Intraoperatively, both patients received large amounts of replacement fluids (0.9% normal saline and albumin), blood transfusion, and sodium bicarbonate during the anhepatic phase, all of which carry high sodium load. Variations in sodium levels changed rapidly in patient 1 during transplant surgery. After they underwent liver transplant, patient 1 had clear mental status and patient 2 demonstrated worsened mental status. On approximately day 14 and day 4 after liver transplant, magnetic resonance imaging showed diffuse abnormalities of the pons, resulting in diagnosis of central pontine myelinolysis. Although both patients survived, 1 remains in a vegetative state and the other continues to present with mild balance and swallowing abnormalities. To reduce the chance of inadvertent overcorrection in patients with hyponatremia, it is therefore important that sodium concentrations should be monitored frequently and fluids and electrolytes titrated carefully.

• Authors: Ya-Lan Hsu, Chia-En Hsieh, Kuo-Hua Lin, Chen-Te Chou, Ping-Yi Lin, Su-Han Wang, Yao-Li Chen
• Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation (Exp Clin Transplant) Vol. 17 Issue 4 Pg. 564-567 (08 2019) ISSN: 2146-8427 [Electronic] Turkey
• PMID: 29137593 (Publication Type: Case Reports)

Chemical References

• Biomarkers
• Sodium

Topics

• Aged
• Biomarkers (blood)
• Female
• Fluid Therapy (adverse effects)
• Humans
• Hyponatremia (blood, diagnosis, therapy)
• Kidney Failure, Chronic (complications, diagnosis, surgery)
• Liver Cirrhosis, Biliary (complications, diagnosis, surgery)
• Liver Transplantation (adverse effects)
• Living Donors
• Middle Aged
• Myelinolysis, Central Pontine (diagnostic imaging, etiology, therapy)
• Risk Factors
• Sodium (blood)
• Treatment Outcome